Cancer Prevention News and Research

RSS

Simple blood test combined with risk model improves lung cancer mortality prediction

A blood-based test developed by researchers at The University of Texas MD Anderson Cancer Center can efficiently predict an individual's risk of dying from lung cancer when combined with a personalized risk model.

28 Jun 2023

World's largest map of breast tissue provides an unprecedented understanding of mammary biology

A new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine and Baylor College of Medicine has created the world's largest and most comprehensive map of normal breast tissue, providing an unprecedented understanding of mammary biology that may help identify therapeutic targets for diseases such as breast cancer.

28 Jun 2023

A recipe for survival: Mediterranean diet and breast cancer outcomes

Study analyzes whether overall and BC-specific mortality was associated with adherence to MD.

28 Jun 2023

Seven risk factors for early onset colorectal cancer in males identified

Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but are increasing for those under 50.

27 Jun 2023

$9.8 million NCI grant aims to combat cancer disparities

Weill Cornell Medicine and Columbia University have been awarded a $9.8 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to help combat cancer disparities fueled by persistent poverty.

26 Jun 2023

Low-cost DNA test for HPV infections could improve access to cervical cancer screening

Rice University bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more than 300,000 women each year.

21 Jun 2023

NCCN guidelines establish an equitable standard of care for cancer outcomes

Today, the National Comprehensive Cancer Network® (NCCN®)-;an alliance of leading cancer centers-;convened a policy summit to examine how geography impacts cancer outcomes.

16 Jun 2023

Historically redlined areas are less likely to be screened for breast, colorectal, and cervical cancer

Although redlining was outlawed more than 50 years ago, new research shows that people today who live in historically redlined areas are less likely to be screened for breast, colorectal, and cervical cancer than people who live in areas not associated with redlining practices.

16 Jun 2023

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London. During the event, NCCN Senior Vice President and Chief Medical Officer, Wui-Jin Koh, MD, will present on NCCN's ongoing global work to define and advance high-quality, high-value, patient-centered cancer care.

14 Jun 2023

Improving prostate cancer screening: accounting for genetic determinants of PSA variation

Researchers conducted a genome-wide analysis of prostate-specific antigen (PSA) levels of men without prostate cancer.

5 Jun 2023

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care

he National Comprehensive Cancer Network-;a not-for-profit alliance of leading cancer centers in the United States-;today announced the signing of a Memo of Understanding (MOU) with Vietnam National Cancer Hospital ("K Hospital") and the Vietnam Cancer Association to work together to improve standards for cancer care throughout the country.

1 Jun 2023

Study suggests licorice-derived liquiritigenin has breast cancer prevention potential for high-risk postmenopausal women

Researchers evaluated the potential of three licorice (Glycyrrhiza) species, i.e., G. glabra (GG), G. uralensis (GU), and G. infata (GI), and hops (Humulus lupulus), and their main bioactive polyphenols, to prevent breast malignancy.

1 Jun 2023

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

Melatonin, a hormone derived from the pineal gland, has diverse effects on cellular processes. This review explores its potential role as an epigenetic regulator, particularly in modulating DNA methylation, and suggests its use in combination therapy as a novel anticancer strategy.

30 May 2023

Study identifies new genes associated with heart attack risk largely affecting younger women

Research led by the National Institute for Health and Care Research Leicester Biomedical Research Centre (BRC) and Universite Paris Cite, and supported by worldwide partners in Canada, the USA and Australia, has identified new genes that are associated with an increased risk of a type of heart attack primarily affecting young to middle-aged women.

29 May 2023

New pan-cancer T cell atlas provides a deeper understanding of complex tumor microenvironment

A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, provides a deeper understanding of the vast diversity of T cell states as well as their relationships and roles within the complex tumor microenvironment, bringing a fresh perspective to understanding immunotherapy efficacy in cancer.

29 May 2023

Cancer Prevention News and Research

Simple blood test combined with risk model improves lung cancer mortality prediction

World's largest map of breast tissue provides an unprecedented understanding of mammary biology

A recipe for survival: Mediterranean diet and breast cancer outcomes

Seven risk factors for early onset colorectal cancer in males identified

$9.8 million NCI grant aims to combat cancer disparities

Low-cost DNA test for HPV infections could improve access to cervical cancer screening

NCCN guidelines establish an equitable standard of care for cancer outcomes

Historically redlined areas are less likely to be screened for breast, colorectal, and cervical cancer

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

Improving prostate cancer screening: accounting for genetic determinants of PSA variation

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care

Study suggests licorice-derived liquiritigenin has breast cancer prevention potential for high-risk postmenopausal women

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

Study identifies new genes associated with heart attack risk largely affecting younger women

New pan-cancer T cell atlas provides a deeper understanding of complex tumor microenvironment

Novel regulators of COPD determined by epigenetic profiling

Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

Focusing on satiety and satiation may be better for weight loss success

Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ checkpoint inhibitor

Study establishes a mechanistic link between obesity and oral cancer immune escape

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News